On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Hillenbrand (United States)

InstitutionResearch output, impact & collaborations

Hillenbrand (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Hillenbrand (United States)?

ScholarIQrecord summary

Hillenbrand (United States) is a research organisation in Batesville, US. OpenAlex records 1,727 works and 44,685 citations for it. 378 researchers list it as their most recent affiliation.

How many works does Hillenbrand (United States) have?

ScholarIQindexed works

Hillenbrand (United States) has 1,727 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Hillenbrand (United States) →

How many citations does Hillenbrand (United States) have?

ScholarIQcitation count

Hillenbrand (United States) has 44,685 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Hillenbrand (United States) →

How many researchers are at Hillenbrand (United States)?

ScholarIQresearcher count

Hillenbrand (United States) has 378 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Hillenbrand (United States)?

ScholarIQavg h-index

Hillenbrand (United States) has an average h-index of 50 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Hillenbrand (United States)?

ScholarIQror

The ROR for Hillenbrand (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Hillenbrand (United States)?

ScholarIQopenalex

The OpenAlex for Hillenbrand (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Hillenbrand (United States)?

ScholarIQtop researchers by citations

Kamy Sepehrnoori · Hydraulic Fracturing and Reservoir Analysis

926 works20,471 citations

Paolo Rossi · Multiple Sclerosis Research Studies

115 works3,699 citations

What are the most-cited papers on Hillenbrand (United States)?

ScholarIQmost cited works

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex<sup>®</sup>), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

Alena Novotná, Jan Mareš, S. Ratcliffe, Iveta Nováková, Marta Vachová, Olga Zapletalová, Claudio Gasperini, Carlo Pozzilli, Luca Ausili Cefaro, Giancarlo Comi, Paolo Rossi, Zdeněk Ambler, Z Stelmasiak, Alf-Peter Erdmann, Xavier Montalbán, A Klimek, Paul Davies, the Sativex Spasticity Study Group

European Journal of Neurology. 2011467 Citations

Default-mode network dysfunction and cognitive impairment in progressive MS

Maria A. Rocca, Paola Valsasina, Martina Absinta, Gianna Carla Riccitelli, Mariaemma Rodegher, Paolo Misci, Paolo Rossi, Andrea Falini, Giancarlo Comi, Massimo Filippi

Neurology. 2010321 Citations

Physiopathology and treatment of fatigue in multiple sclerosis

Gıancarlo Comı, Letizia Leocani, Paolo Rossi, B. Colombo

Journal of Neurology. 2001196 Citations

Fatigue in Multiple Sclerosis Is Associated with Abnormal Cortical Activation to Voluntary Movement—EEG Evidence

Letizia Leocani, B. Colombo, Giuseppe Magnani, Filippo Martinelli Boneschi, Marco Cursi, Paolo Rossi, Vittorio Martinelli, Gıancarlo Comı

NeuroImage. 2001161 Citations

Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis

María Trojano, Fabio Pellegrini, Damiano Paolicelli, Aurora Fuiani, Giovanni Bosco Zimatore, Carla Tortorella, Isabella Laura Simone, Francesco Patti, Angelo Ghezzi, Valentina Zipoli, Paolo Rossi, Carlo Pozzilli, Giuseppe Salemi, Alessandra Lugaresi, Roberto Bergamaschi, Enrico Millefiorini, Marinella Clerico, Giacomo Lus, Marika Vianello, Carlo Avolio, Paola Cavalla, Vito Lepore, Paolo Livrea, Giancarlo Comi, Maria Pia Amato, Italian Multiple Sclerosis Database Network (MSDN) Group

Annals of Neurology. 2009144 CitationsOPEN ACCESS

How much of the research on Hillenbrand (United States) is open access?

ScholarIQopen access share

36%OPEN ACCESS

Gold

27%

Green

Hybrid

Bronze

Closed

64%